Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Peter Marks

The Power List 2021 – Advanced Medicine


Director at the FDA Center for Biologics Evaluation and Research

Over the past 12 months, Marks has played a pivotal role at the FDA in ensuring that COVID-19 vaccines are both safe and effective. Weighing in on how the pandemic may impact cell and gene therapy, he says, “The holistic approach to product development, simultaneously focusing on manufacturing challenges and clinical development combined with increased sponsor-agency interactions could potentially propel cell and gene therapy product development forward more rapidly.”

For the future, he is most excited about the application of genome editing with base editors or similar technologies to the treatment of human disease, which he thinks could be a “game-changer,” as well as the application of advanced manufacturing technologies to cell and gene therapy production.


Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register